THE APS PASSPORT: Innovative Pharmacy Technology That Improves Post-Acute Care Whitepaper Results‚Äč

Beginning in 2018, a national pharmaceutical distributor conducted an 18-month field study of the APS Passport Dispensing System to better understand and validate the true realized value of APS Passport technology.

The study was conducted over an 18-month period and involved 52 facilities; more than 52 elements of measure were captured for analysis. Performance elements included customer feedback and benefits, including quality, time savings, workflow savings, ease of use and adoption, space savings and reduction in drug waste.

Fill out the form to learn more about the value of APS Passport, the clinical and financial benefits of the technology, and the positive impact APS Passport is having on long-term care facilities and their patients across the country.

See what Partners Pharmacy’s COO, Anthony Spero, has to say about this study! We’re so excited to share our findings with you.